Like TKIs in RCC and CML, epidermal growth factor receptor (EGFR) TKIs are also metabolized by cytochrome P450s and are substrates of p-glycoprotein and BCRP. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.